Current Update on New Delhi Metallo-β-lactamase (NDM) Variants: New Challenges in the Journey of Evolution

被引:3
|
作者
Farooq, Samiya [1 ]
Khan, Asad U. [1 ]
机构
[1] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh 202002, India
关键词
Gram-negative bacteria; hydrolysis; amino acid residues; drug-resistant infections; inhibitors; NDM; RESISTANT ESCHERICHIA-COLI; CLINICAL ISOLATE; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; ENTEROBACTERIACEAE; IDENTIFICATION; STRAIN; REVEALS; CARBAPENEMASES; HYDROLYSIS;
D O I
10.2174/1389203724666230816154117
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New Delhi Metallo-beta-lactamase is an enzyme produced by gram-negative bacteria which has become one of the global concerns for physicians to treating the infection. These Metallo-beta-lactamase are capable of catalyzing the hydrolysis of almost all beta-lactam antibiotics, endangering infection treatment. Substitution of single or multiple amino acids results in new NDM variants. Forty NDM variants have been identified in different bacterial strains across the globe. In this review, we focused on the structural insight of all NDM variants including the type of amino acid residues and their position of substitution, country of origin, and type of bacteria carrying these resistant markers. We also discussed the carbapenemase activity and stability of enzymes that helps to design potent inhibitors to combat drug-resistant infections.
引用
收藏
页码:655 / 665
页数:11
相关论文
共 50 条
  • [21] Response to "New Delhi Metallo-β-lactamase (NDM-1): an emerging Threat Among Enterobacteriaceae"
    Arya, Subhash C.
    Agarwal, Nirmala
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (12) : 921 - 922
  • [22] Discovery of an Effective Small-Molecule Allosteric Inhibitor of New Delhi Metallo-β-lactamase (NDM)
    Thomas, Pei W.
    Cho, Eun Jeong
    Bethel, Christopher R.
    Smisek, Thomas
    Ahn, Yeong-Chan
    Schroeder, John M.
    Thomas, Caitlyn A.
    Dalby, Kevin N.
    Beckham, Josh T.
    Crowder, Michael W.
    Bonomo, Robert A.
    Fast, Walter
    ACS INFECTIOUS DISEASES, 2022, 8 (04): : 811 - 824
  • [23] Covalent Inhibition of New Delhi Metallo-β-Lactamase-1 (NDM-1) by Cefaclor
    Thomas, Pei W.
    Cammarata, Michael
    Brodbelt, Jennifer S.
    Fast, Walter
    CHEMBIOCHEM, 2014, 15 (17) : 2541 - 2548
  • [24] Azolylthioacetamides as potential inhibitors of New Delhi metallo-β-lactamase-1 (NDM-1)
    Xiao-Long Liu
    Yang Xiang
    Cheng Chen
    Ke-Wu Yang
    The Journal of Antibiotics, 2019, 72 : 118 - 121
  • [25] Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity
    Goettig, Stephan
    Hamprecht, Axel G.
    Christ, Sara
    Kempf, Volkhard A. J.
    Wichelhaus, Thomas A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (08) : 1737 - 1740
  • [26] Global spread of New Delhi metallo-β-lactamase 1
    Bogaerts, Pierre
    Verroken, Alexia
    Jans, Beatrice
    Denis, Olivier
    Glupczynski, Youri
    LANCET INFECTIOUS DISEASES, 2010, 10 (12): : 831 - 832
  • [27] Emergence of New Delhi metallo-β-lactamase in Jerusalem, Israel
    Lachish, Tamar
    Elimelech, Meital
    Arieli, Natalie
    Adler, Amos
    Rolain, Jean-Marc
    Assous, Marc Victor
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 40 (06) : 566 - 567
  • [28] New Delhi Metallo-β-lactamase-1 (NDM-1): An Emerging Threat Among Enterobacteriaceae
    Hsueh, Po-Ren
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (10) : 685 - 687
  • [29] Multidisciplinary approach to design New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors
    Kurbanov, Elbek
    Cohen, Seth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [30] Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance
    Johnson, Alan P.
    Woodford, Neil
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 499 - 513